Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Efficient immunization of rhesus macaques with an HCV candidate vaccine by heterologous priming-boosting with novel adenoviral vectors based on different serotypes.

Fattori E, Zampaglione I, Arcuri M, Meola A, Ercole BB, Cirillo A, Folgori A, Bett A, Cappelletti M, Sporeno E, Cortese R, Nicosia A, Colloca S.

Gene Ther. 2006 Jul;13(14):1088-96. Epub 2006 Mar 23.

PMID:
16554842
2.

A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees.

Folgori A, Capone S, Ruggeri L, Meola A, Sporeno E, Ercole BB, Pezzanera M, Tafi R, Arcuri M, Fattori E, Lahm A, Luzzago A, Vitelli A, Colloca S, Cortese R, Nicosia A.

Nat Med. 2006 Feb;12(2):190-7. Epub 2006 Feb 5.

PMID:
16462801
3.

An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors.

Catalucci D, Sporeno E, Cirillo A, Ciliberto G, Nicosia A, Colloca S.

J Virol. 2005 May;79(10):6400-9.

4.
5.

Long-term and tight control of gene expression in mouse skeletal muscle by a new hybrid human transcription factor.

Roscilli G, Rinaudo CD, Cimino M, Sporeno E, Lamartina S, Ciliberto G, Toniatti C.

Mol Ther. 2002 Nov;6(5):653-63.

6.

Stringent control of gene expression in vivo by using novel doxycycline-dependent trans-activators.

Lamartina S, Roscilli G, Rinaudo CD, Sporeno E, Silvi L, Hillen W, Bujard H, Cortese R, Ciliberto G, Toniatti C.

Hum Gene Ther. 2002 Jan 20;13(2):199-210.

PMID:
11812277
8.

The receptor super-antagonist Sant7.

Savino R, Demartis A, Ciapponi L, Sporeno E, Toniatti C, Bernassola F, Melino G, Klein B, Ciliberto G.

Oncol Rep. 1997 May-Jun;4(3):485-92.

PMID:
21590082
9.

Human interleukin-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cells.

Sporeno E, Savino R, Ciapponi L, Paonessa G, Cabibbo A, Lahm A, Pulkki K, Sun RX, Toniatti C, Klein B, Ciliberto G.

Blood. 1996 Jun 1;87(11):4510-9.

PMID:
8639818
10.

Monovalent phage display of human interleukin (hIL)-6: selection of superbinder variants from a complex molecular repertoire in the hIL-6 D-helix.

Cabibbo A, Sporeno E, Toniatti C, Altamura S, Savino R, Paonessa G, Ciliberto G.

Gene. 1995 Dec 29;167(1-2):41-7.

PMID:
8566809
11.

Production and structural characterization of amino terminally histidine tagged human oncostatin M in E. coli.

Sporeno E, Barbato G, Graziani R, Pucci P, Nitti G, Paonessa G.

Cytokine. 1994 May;6(3):255-64.

PMID:
8054481
12.

Oncostatin M binds directly to gp130 and behaves as interleukin-6 antagonist on a cell line expressing gp130 but lacking functional oncostatin M receptors.

Sporeno E, Paonessa G, Salvati AL, Graziani R, Delmastro P, Ciliberto G, Toniatti C.

J Biol Chem. 1994 Apr 15;269(15):10991-5.

13.

Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activation.

Savino R, Lahm A, Salvati AL, Ciapponi L, Sporeno E, Altamura S, Paonessa G, Toniatti C, Ciliberto G.

EMBO J. 1994 Mar 15;13(6):1357-67.

14.

The uvp1 gene of plasmid pR cooperates with mucAB genes in the DNA repair process.

Gigliani F, Sporeno E, Perri S, Battaglia PA.

Mol Gen Genet. 1989 Jul;218(1):18-24.

PMID:
2550763
15.

Cellular response to DNA damage is enhanced by the pR plasmid in mouse cells and in Escherichia coli.

Marcucci L, Gigliani F, Battaglia PA, Bosi R, Sporeno E, Elli R.

Mol Cell Biol. 1986 Feb;6(2):586-92.

Supplemental Content

Loading ...
Support Center